Goldman Sachs takes some of the shine off of Clorox's (CLX) FQ2 earnings beat (I, II) by noting...

|About: The Clorox Company (CLX)|By:, SA News Editor

Goldman Sachs takes some of the shine off of Clorox's (CLX) FQ2 earnings beat (I, II) by noting transitory factors had a significant role. The firm thinks a lease-back gain and revenue pulled forward from FQ3 made the the company's numbers rosier than they actually were.